1370007-53-6 Usage
General Description
7-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one is a chemical compound with the molecular formula C6H3BrN4O. It is a heterocyclic organic compound that contains a pyrrolo-triazinone skeleton. 7-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one is utilized in medicinal chemistry research for the development of potential pharmaceutical drugs targeting different diseases and conditions. Its unique chemical structure makes it a valuable building block for the synthesis of various derivatives with potential biological activities. Additionally, it also serves as a useful intermediate in the production of other complex organic molecules. Furthermore, its properties and potential applications make it of interest to chemists and researchers in the field of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1370007-53-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,0,0,0 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1370007-53:
(9*1)+(8*3)+(7*7)+(6*0)+(5*0)+(4*0)+(3*7)+(2*5)+(1*3)=116
116 % 10 = 6
So 1370007-53-6 is a valid CAS Registry Number.
1370007-53-6Relevant articles and documents
AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS
-
, (2019/08/12)
The disclosure relates to compounds of formula I which are useful as kinase modulators including RIPK1 modulation. The disclosure also provides methods of making and using the compounds for example in treatments related to necrosis or inflammation as well as other indications.
3H-THIENO[3,4]PYRIMIDIN-4-ONEAND PYRROLOPYRIMID-4-ONE AS GRAM-POSITIVE ANTIBACTERIAL AGENTS
-
Page/Page column 88, (2015/09/28)
The invention relates to novel heteroaromatic derivatives of formula (I) and their addition salts thereof with acids and bases; their preparation, their use as drugs and pharmaceutical compositions and associations containing them. wherein A, B, T, V, X and Y represent organic substituents as defined herein, The compounds of formula (I) are able to inhibit the activity of the Gram-positive bacterial DltA enzyme and they are used to prevent and/or treat Gram-positive bacterial infections in humans or animals, alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity,
